A new study suggests that a fasting-mimicking diet may reduce systemic inflammation in patients with periodontitis, according to research published in a 2024 Spanish pilot study.

Parodontitis, a chronic bacterial infection affecting the teeth-supporting structures, has been linked to systemic health risks, including cardiovascular disease and diabetes. A recent pilot study explored whether a “fasting-mimicking diet” (FMD), also known as Scheinfasten, could complement non-surgical periodontal treatment by lowering inflammation markers. The findings, published in ScienceDirect, indicate that FMD may reduce systemic inflammation, though clinical improvements in oral health were not significantly enhanced.

What Is Parodontitis and Why Is It a Concern?

Parodontitis, or gum disease, involves chronic inflammation of the gums, leading to damage of the jawbone and surrounding tissues. According to the Centers for Disease Control and Prevention (CDC), it affects nearly half of adults over 30 in the U.S. The condition is associated with systemic inflammation, as bacteria and inflammatory byproducts from the mouth can enter the bloodstream, potentially worsening conditions like atherosclerosis and metabolic disorders.

How Does Scheinfasten Work?

Scheinfasten, or a fasting-mimicking diet, is a calorie-reduced regimen designed to replicate the metabolic benefits of fasting without complete food deprivation. Developed by researchers at the University of Southern California, the diet emphasizes low protein, low sugar, and high healthy fat intake. Studies suggest it may reduce inflammation and promote cellular repair by triggering autophagy, a process where the body removes damaged cells.

What Did the Study Reveal?

The 2023–2024 study, conducted at five Spanish universities, involved 28 participants with periodontitis. Half followed a non-surgical treatment plan (scaling and root planing) plus three five-day FMD cycles, while the other half received only standard care. Researchers measured inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), a key indicator of systemic inflammation.

Both groups showed improvements in oral health metrics, such as reduced gum bleeding and plaque. However, the FMD group experienced a more pronounced decline in hs-CRP levels, suggesting a potential anti-inflammatory effect. “The reduction in systemic inflammation markers was statistically significant in the FMD group,” the study authors noted.

Why Are the Results Important?

The findings highlight a possible role for FMD in managing periodontitis-related systemic inflammation. Chronic inflammation is a known risk factor for conditions like heart disease and diabetes, so interventions that address this link could have broader health implications. However, the study did not find significant differences in clinical outcomes like gum pocket depth or attachment loss between the groups.

What Are the Study’s Limitations?

The pilot study’s small sample size (28 participants) and short follow-up period (six months) limit its generalizability. Researchers acknowledged that the lack of objective measures, such as ketone levels or blood glucose tracking, made it difficult to confirm adherence to the FMD. Additionally, the control group had a higher proportion of women, which could influence results. “Larger, longer-term trials are needed to validate these findings,” the authors concluded.

What Does This Mean for Patients?

While the study suggests FMD may help reduce systemic inflammation, it is not a substitute for standard periodontal care. Patients should consult their dent